Human erythrocyte ghosts exhibit an inositol trisphosphate phosphomonoesterase activity that rapidly converts inositol 1,4,5-trisphosphate into inositol 1,4-bisphosphate and P. Degradation of the released inositol 1,4-bisphosphate is not observed. This activity is dependent on Mg2+ (or Mn2+) and it is not activated by Ca2+. Optimum activity is around pH 7 and activity is abolished by heat denaturation. The Km for inositol trisphosphate is approx. 25 pM. 2,3-Bisphosphoglycerate is a competitive inhibitor, with a K; of approx. 0.35 mm. Glycerophosphoinositol 4,5-bisphosphate is attacked at about one-eighth of the rate for inositol trisphosphate, but glycerophosphoinositol 4-phosphate is not a substrate. Incubation of 32P-labelled erythrocyte membranes with Mg2+ causes little breakdown of phosphatidylinositol 4,5-bisphosphate, the parent compound from which both glycerophosphoinositol 4,5-bisphosphate and inositol 1,4,5-trisphosphate are derived. On the basis of its substrate specificity and the inhibition by 2,3-bisphosphoglycerate, we suggest that this enzyme is selective for the 5-phosphate in those water-soluble phosphate esters of inositol that possess the vicinal pair of 4,5-phosphates but that it may also interact less strongly with other water-soluble compounds that have pairs of vicinal phosphates.
Three inositol phospholipids, namely phosphatidylinositol, phosphatidylinositol 4-phosphate (Ptdlns4P) and phosphatidylinositol 4,5-bisphosphate [Ptdlns(4, 5) P2] appear likely to be constituents of all eukaryote cells (Michell, 1975; Hawthorne & White, 1975) . In addition, a ubiquitous effect of hormones and neurotransmitters that use Ca2+ as their second messenger is to cause the breakdown of phosphatidylinositol, probably by a phosphodiesterase that releases a mixture of inositol 1-phosphate and inositol 1:2-cyclic phosphate (see Michell, 1975; . PtdIns4P and PtdIns(4,5)P2 are also susceptible to degradation by phosphodiesterases, yielding Ins(1,4)P2 and Ins(1,4,5)P3 respectively. Recent studies have revealed situations in which such phosphodiesterases become activated by Ca2+ in erythrocytes (Allan & Michell, 1978; Abbreviations used: PtdIns4P, 1-(3-sn-phosphatidyl)-L-myo-inositol 4-phosphate; Ptdlns(4,5)P2, 1-(3-sn-phosphatidyl)-L-myo-inositol 4,5-bisphosphate; Ins(1,4)P2, Lmyo-inositol 1,4-bisphosphate; Ins(1,4,5)P3, L-myoinositol 1,4,5-trisphosphate. * Present address: MRC Neurochemical Pharmacology Unit, Medical Research Council Centre, Medical School, Hills Road, Cambridge CB2 2QH, U.K. Michell, 1981a,b; Allan & Thomas, 1981a,b) or synaptosomes (Griffin & Hawthorne, 1978) , or through activation of certain cell-surface receptors in iris smooth muscle (see Akhtar & Abdel-Latif, 1980) and probably also in hepatocytes Kirk et al., 1981) . Although it seems unlikely that the stimulatory effects of Ca2+ on the polyphosphoinositide phosphodiesterase are ever expressed at the cytosolic [Ca2+I prevalent in healthy cells , it seems probable that the activation caused by hormones and neurotransmitters is a normal occurrence that would continuously liberate small quantities of Ins(1,4)P2 and Ins(1,4,5)P3 in cells. If this were so, then there would be a need for enzymic mechanisms to degrade these inositol polyphosphates. Breakdown of inositol trisphosphate has recently been observed both in iris smooth muscle (Ahktar & Abdel-Latif, 1980) and in human erythrocyte membranes (Downes & Michell, 198 la). The present paper describes in more detail the characteristics of the Ins(1,4,5)P3 phosphomonoesterase of the erythrocyte membrane.
Materials and methods
Human blood was obtained from the Blood Vol. 203
Transfusion Centre within 7 days of donation. 2,3-Bisphosphoglycerate was from Sigma (London) Chemical Company, and other reagents were from sources specified previously (Downes & Michell, 1981a ,b, 1982 .
Preparation of 32P-labelled Ins(1,4)P2 and Ins(1,4,5)P3 32P-labelled erythrocyte ghosts were prepared as described previously (Downes & Michell, 1981a) .
The ghosts were incubated in the presence of 1 mM-Ca2+ at 370C for 30min to activate the membrane-bound polyphosphoinositide phosphodiesterase and thus liberate radioactive Ins(1,4)P2 and Ins(1,4,5)P3 from the polyphosphoinositides (Allan & Michell, 1978; Downes & Michell, 1981a) . The incubations were diluted with ice-cold water and the membranes sedimented by centrifugation at 15 000g for 15min at 40C. The membrane-free supernatant, which contained the inositol phosphates, was applied to a column containing 1 ml of Dowex-1 (formate form; 100-200 mesh). Ins(1,4)P2 and Ins(1,4,5)P3 were sequentially eluted from the column by using ammonium formate and formic acid solutions as described previously (Downes & Michell, 1981a) . Column eluates were freed of ammonium ions by treatment with Dowex-50 (H+ form) and were freeze-dried. The dried samples were dissolved in water and stored frozen.
Preparation of 32P-labelled glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4,5-bisphosphate These were prepared from the same samples of labelled erythrocyte ghosts as those used for the preparation of inositol phosphates. Phospholipids were extracted from the membranes by the method of Allan & Michell (1978) . They were deacylated and the products separated on Dowex-1 (formate formt) as described previously (Downes & Michell, 198 la): this procedure gave a quantitative conversion of lipid-soluble 32p into water-soluble 32p, and the only radioactive products detected by high-voltage electrophoresis were glycerophosphate, glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4,5-bisphosphate. To obtain the latter two esters at convenient specific radioactivities, an appropriate sample of Folch fraction I/II (Folch, 1949) , a lipid mixture enriched in PtdIns4P and PtdIns(4,5)P2, was sometimes added before deacylation and ion-exchange chromatography. Simple treatment of these column eluates with Dowex-50 (to yield cation-free samples of these two esters) generated relatively concentrated solutions of formic acid, which caused considerable hydrolysis of the phosphodiester bond, thus leading to contamination of the samples with inositol phosphates during subsequent handling. To avoid this problem, the eluates were diluted 3-fold with water and applied to 0.2ml columns of Dowex-1 (formate form). The phosphate esters were then eluted with 3ml of 2M-LiCl. After freeze-drying, LiCl was removed by extraction with 4x4ml of ethanol. The salt-free samples were dried under vacuum, taken up in a small volume of water and stored frozen.
Preparation of unlabelled glycerophosphoinositol 4-phosphate and glycerophosphoinositol 4,5-bisphosphate These were prepared exactly as described for the labelled compounds, the starting material being a sample of Folch fraction I/II from ox brain.
Analysis ofphosphate ester preparations
The identities of the isolated phosphate esters were confirmed by high-voltage electrophoresis on Whatman no. 1 paper in a pyridine/acetic acid buffer (pH3.5) at 50V/cm for 75min as described previously (Dawson et al., 1962; Dawson & Clarke, 1972; Allan & Michell, 1978) . Radioactive compounds were detected by autoradiography and phosphate-containing compounds by using the Hanes and Isherwood reagent as modified by Dawson (1960) . Each radioactive sample migrated as a single component with the expected electrophoretic mobility (relative to P). The unlabelled glycerophosphoinositol 4-phosphate and 4,5-bisphosphate showed the expected electrophoretic mobilities and were uncontaminated by other phosphate-containing compounds. The concentrations of the final phosphate ester preparations were determined by phosphate analysis by the method of Bartlett (1959) .
In a typical preparation starting from 30ml of packed erythrocytes that had been labelled for 2h at 370C with l.OmCi of [ 32p]p; (see Downes & Michell, 1981a, Isolation oferythrocyte ghosts Permeable erythrocyte ghosts were prepared by hypo-osmotic lysis of packed cells as described previously (Downes & Michell, 1981b) . After the usual isolation in 2.5 mM-Hepes/I mM-EGTA, the membranes were given a final wash in 10vol of 1.5 mM-Hepes, pH 7.2, containing 0.154 M-NaCi. This procedure removed contaminating haemoglobin and some Mg2+-independent Ins(1,4,5)P3 phosphomonoesterase activity; the latter could account for up to 10% of the total membraneassociated activity in ghosts that had not been washed with an 'isotonic' salt solution.
The protein content of ghost preparations was determined by the-method of Lowry et al. (1951) . 1ns(J,4,5)P3 phosphomonoesterase assay For analysis of the products of membranecatalysed breakdown, Ins(1 ,4,5)P3 (10-1OOUM) was incubated with 30mM-Hepes [4-(2-hydroxyethyl)-1-piperazine-ethanesulphonic acid], pH 7.0, containing 2 mM-Mg2+ and 0.4-1 mg of membrane protein in 1ml at 370C for various times. Assays were stopped by the addition of an equal volume of 20% (w/v) trichloroacetic acid, kept on ice for 10min and the precipitated proteins sedimented by centrifugation. Trichloroacetic acid was extracted from the supernatant with diethyl ether (4 x 4 volumes) and the aqueous samples were neutralized with NaOH. These were then applied to columns containing 1 ml of Dowex-1 (formate form). The columns were eluted sequentially with ammonium formate/formic acid solutions to separate Pi, inositol bisphosphate and Ins(1,4,5)P3 (Downes & Michell, 198 la) . Radioactivity in fractions obtained from columns was determined by Cerenkov counting.
As shown in the Results section, the Ins(1,4,5)P3 phosphomonoesterase of the erythrocyte membrane only removes the 5-phosphate. This presented a problem when we came to devise a simplified enzyme assay that was based on the release of [32pIp ; only the 60-80% of the 32p of any individual preparation of Ins(1,4,5)P3 that was in the 5-phosphate would be released as Pi, even when all of the Ins(1,4,5)P3 was hydrolysed. For each preparation of substrate, therefore, a sample was incubated with erythrocyte ghosts until about half was hydrolysed, and the proportions of the total radioactivity that were in P1 (i.e. the 5-phosphate) and in Ins(1,4)P2 (i.e. the 4-phosphate) determined. In presentation of kinetic experiments, [32p]p; release was then expressed in terms of only the release of that fraction of the radioactivity that was initially in the 5-phosphate.
For the simplified assay, Ins(1,4,5)P3 (or another phosphate ester) was incubated in a final volume of 30-200,u1 (this was varied, depending on the final concentration of substrate and the amount of Vol. 203 radioactive substrate needed) containing 30 mmHepes and, generally, 2mM-Mg2+. The reaction was started by the addition of erythrocyte membranes (0.4-0.7mg of protein per ml of assay mixture). Incubations were stopped after 15 min by addition of lM-HCl04 to give a final volume of 1 ml. After centrifugation, a sample of the supernatant was removed and made 1% (w/v) with respect to ammonium molybdate (the precipitated protein was removed because addition of ammonium molybdate in the presence of denatured membranes resulted in substantial binding of P, to the pellet). Isobutyl alcohol/toluene (1:1, v/v; 2 vol.) was then added and the sample mixed vigorously. A sample of the upper, organic phase, containing only P;, was removed and mixed with one-third of its volume of methanol and 3 vol. of toluene scintillant, and its radioactivity was determined by scintillation counting.
Analysis ofthe products ofIns(1,4,5)P3 breakdown
In addition to Pi, a smaller amount of 32p was found in the inositol bisphosphate fraction after incubation of membranes with inositol trisphosphate and the separation of the products on Dowex-1 (see the Results section). For further analysis, this fraction was desalted and freeze-dried (see above). The inositol bisphosphate was dissolved in water containing a slight molar excess of cyclohexylamine and subjected to paper chromatography for 24 h on Whatman no. 1 paper in propan-2-ol-conc. NH3 (sp.gr. 0.88)-water (5:4:1, by vol.) (Desjobert & Petek, 1956) . Radioactive compounds were located by autoradiography using X-ray film.
In addition, the liberated inositol bisphosphate was subjected to periodate oxidation (Chang & Ballou, 1967; Prottey et al., 1968) . A sample containing approx. 0.1 umol of inositol bisphosphate was incubated in 1 ml of 50mM-sodium periodate, pH 4.0-5.0, in the dark at 370C. Samples were removed at intervals and the radioactivity present as P1 and as organic phosphate was determined by solvent partition of the molybdate complex of Pi (see above). A sample of radiochemically pure Ins(1,4)P2 produced by phosphodiesterase cleavage of erythrocyte PtdIns4P (Downes & Michell, 198 la) was simultaneously oxidized under identical conditions.
Results
In our original experiments, 32P-labelled erythrocyte ghosts were incubated with Ca2+ to activate a membrane-bound polyphosphoinositide phosphodiesterase. The Ins(1,4)P2 and Ins(1,4,5)P3 released by this activity were then separated by ion-exchange chromatography. In the presence of Mg2+, the released Ins(1,4,5)P3 was further degraded to a compound that eluted with Ins(1,4)P2, and this appeared to be relatively stable in the presence of erythrocyte membranes and Mg2+. We therefore thought that erythrocyte membranes possessed an Ins(1,4,5)P3 phosphomonoesterase (Downes & Michell, 1981a) . We have now characterized this activity further by using purified radioactive inositol phosphates and related compounds as substrates.
The products ofinositol trisphosphate breakdown
The results from the fractionation on Dowex-1 (formate form) of the trichloroacetic acid-soluble products generated during incubation of Ins(1,4,5)P3 with erythrocyte membranes and Mg2+ are shown in Table 1 . After incubation for 30min at 370C in the presence of Mg2+, almost two-thirds of the radioactivity from Ins(1,4,5)P3 was found in the fractions containing Pi and inositol bisphosphate, with about three times as much radioactivity in Pi as in inositol bisphosphate. Solvent partition of the molybdate complex (see above) confirmed that all of the radioactivity in the first fraction was P,. There was no appreciable activity in the absence of Mg2+. Since only the 4-and 5-phosphate groups will be labelled in the Ins(1,4,5)P3 that is derived from erythrocyte Ptdlns(4,5)P2, the obvious interpretation for this selective release of highly labelled P, was that one of these phosphomonoesters was being selectively removed by phosphomonoesterase activity.
The identity of the compound(s) eluting in the 'inositol bisphosphate' fraction was examined in more detail, using samples obtained from experiments in which about 0.1,umol of labelled inositol bisphosphate was degraded by incubation with erythrocyte membranes. A single radioactive compound was detected by paper chromatography and this co-chromatographed precisely with Ins(1,4)P2 derived from PtdIns4P.
Periodate oxidation has been used previously to positively identify the 1,4-isomer of inositol bisphosphate (Chang & Ballou, 1967; Prottey et al., 1968) . Only para-isomers of inositol bisphosphate yield P1 on periodate treatment, and Ins(1,4)P2 is the only such isomer that can arise from Ins(1,4,5)P3. Thompson & Dawson, 1964a,b; Hawthorne & White, 1975; Michell, 1975) . Ptdlns(4,5)P2 phosphomonoesterase specifically removes the 5-phosphate to give the naturally occurring PtdIns4P (Chang & Ballou, 1967; Prottey et al., 1968) . Although it has been reported that erythrocyte membranes do not show Ptdlns(4,5)P2 phosphomonoesterase activity (Hokin & Hokin, 1964) , it seemed essential, in view of the observed Ins(1,4,5)P3 phosphomonoesterase activity, to determine whether our membrane preparations could degrade either the parent lipid (present in the same membranes) or glycerophosphoinositol 4,5-bisphosphate derived from this lipid by alkaline deacylation. When 32P-labelled erythrocyte ghosts containing labelled PtdIns4P and Ptdlns(4,5)P2 were incubated with 2mM-Mg2+ for 30min at 370C there was a very slight loss of radioactivity from Ptdlns(4,5)P2, compared with control samples incubated with EDTA ( was hydrolysed far more rapidly by the membrane-bound phosphomonoesterase than was Ptdlns(4,5)P2, its parent lipid in the membranes. The substrate specificity of the inositol trisphosphate phosphomonoesterase was further assessed by using other 32P-labelled phosphate esters as putative substrates in our routine assay procedures. Ins(1,4,5)P3 and glycerophosphoinositol 4,5-bisphosphate were both substrates, with the former being attacked at about eight times the rate of the latter: at 60 gM substrate, the rates of attack were 2.5 nmol of Ins(1,4,5)P3/mg of membrane protein per min and 0.32nmol of glycerophosphoinositol 4,5-bisphosphate/mg of protein per min. Neither Ins(1,4)P2 nor glycerophosphoinositol 4-phosphate was hydrolysed at a detectable rate.
The positional specificity of glycerophosphoinositol 4,5-bisphosphate breakdown was then examined by comparing the distributions of radioactivity in P; and organic phosphate after its hydrolysis and after the simultaneous hydrolysis of Ins(1,4,5)P3 derived from the same samples of Ptdlns(4,5)P2. After Ins(1,4,5)P3 breakdown the released P, (i.e. the 5-phosphate) possessed 2.42 times the radioactivity of Ins(1,4)P2 (i.e. the radioactivity of the 4-phosphate). The Pi released during glycerophosphoinositol 4,5-bisphosphate breakdown had 2.74 times the activity of glycerophosphoinositol 4-phosphate, i.e. an almost identical distribution of 32p to that during the breakdown of Ins(1,4,5)P3. This demonstrates that the glycerophosphoinositol 4,5-bisphosphate phosphomonoesterase activity also proceeded by the specific liberation of the 5-phosphate.
Properties ofthe Ins(1,4,5)P3 phosphomonoesterase
The following results were all obtained using the Table 2 . Thephosphomonoesterase is much more active against Ins(1,4,5)P3 than PtdIns(4,5)P2 32P-labelled erythrocyte ghosts (0.5 ml) were incubated in a final volume of 1.0 ml containing I mM-EDTA, 2 mmMg2+ or 1mM-Ga2+. Samples containing 1mM-Ca2+ were stopped after 30min or incubated for a further 15 min after adding appropriate concentrations of EGTA (to bring the final concentration to 2 mM) or of EGTA and Mg2+ (to bring the final concentration of each to 2 mM). Reactions were stopped by the addition of 1 ml of 10% trichloroacetic acid and the radioactive polyphosphoinositides and/or inositol phosphates analysed (Downes & Michell, 198 Fig. 4 ). Membrane concentrations and periods of incubation were usually chosen so as to ensure that <25% of the substrate was degraded and the experiments thus yielded approximate initial reaction rates that were between 50% and 70% of Vmax..
The Ins(1,4,5)P3 phosphomonoesterase activity of erythrocyte ghosts was completely inactivated by incubation of the membranes in a boiling-water bath for 2min. There was no detectable activity in the presence of 1 mM-EDTA. Negligible hydrolysis of Ins(1,4,5)P3 occurred in the absence of membranes.
The effects of pH on Ins(1,4,5)P3 hydrolysis are shown in Fig. 2 ; 20mM-Hepes/20mM-cacodylate buffers were used (cacodylate had no effect on activity at pH7.0). Greatest activity was exhibited around pH 7.0.
Bivalent cations were required for enzymic attack on Ins(1,4,5)P3. Mg2+ appears likely to be the activating species in vivo, but Mn2+ could substitute partially, giving up to 50% of the activity obtained with Mg2+ (Fig. 3) . Maximum activity required about 1-5mM-Mg2+ and substantially higher concentrations (12mM) caused slight inhibition (result not shown). There was no detectable activity in the presence of 5 mM-Ca2+, and Ca2+ inhibited the Mg2+-stimulated reaction (result not shown). 
1982
Inhibitors Several phosphate esters were tested to see whether they would inhibit the Ins(1,4,5)P3 phosphomonoesterase. Unlabelled glycerophosphoinositol 4,5-bisphosphate (0.35 mM), a known substrate (see above), inhibited the hydrolysis of 60pM-Ins( 1 ,4,5)P3 by 76%. Unexpectedly, 0.4 mMIns(1,4)P2, which is produced during Ins(1,4,5)P3 breakdown, did not inhibit, but 0.35 mM-glycerophosphoinositol 4-phosphate produced 40% inhibition.
A variety of nucleotides and sugar phosphates were tested, of which the only relatively potent inhibitor was 2,3-bisphosphoglycerate. This, like Ins(1,4,5)P3 and glycerophosphoinositol 4,5-bisphosphate, possesses a pair of vicinal phosphate groups. Inhibition by 2,3-bisphosphoglycerate of the hydrolysis of Ins(1,4,5)P3 was therefore examined more closely, using substrate concentrations from 0.5 to 5 times the Km, and the data were analysed by the method of Dixon (see Comish-Bowden, 1979 
Subcellular distribution
The protein content of erythrocyte ghost preparations varies substantially, depending on the ionic composition of the lysis medium (Bramley et al., 1971; Bramley & Coleman, 1972; Schwoch & Passow, 1973) . To ensure that the observation of a membrane-bound enzyme was not an artefact of the preparation procedure, experiments were done using samples of an isoionic preparation of erythrocyte membranes (Billah et al., 1976 (Billah et al., ,-1977 ) that had been made permeable with Triton X-100. The membrane associated activity remained constant throughout the isolation of these haemoglobin-free ghosts. In addition, there was a readily detectable soluble activity that also degraded Ins(1,4,5)P2 in preference to Ins(1,4)P2 and required Mg2+ (C. P. Downes, M. C. Mussat & R. H. Michell, unpublished work). Thus it seems possible that erythrocytes possess two enzymes capable of degrading Ins(1,4,5)P3 in a specific manner, with one firmly bound to the membrane and the other in the cytosol. Roach & Palmer (1981) have recently described a cytosolic Ptdlns(4,5)P2 phosphomonoesterase in human erythrocytes that also attacks Ins(1,4,5)P3: we suspect that this is responsible for the Ins(1,4,5)P3 phosphomonoesterase activity that we observed in erythrocyte cytosol.
Discussion
Ins(1,4,5)P3 phosphatase in the erythrocyte
We previously showed that human erythrocyte membranes display phosphomonoesterase activity towards Ins(1,4,5)P3 (Downes & Michell, 1981a) , and the results presented here demonstrate that such membranes possess an Mg2+-dependent phosphomonoesterase that selectively attacks only the 5-phosphate of Ins(1,4,5)P3 and of glycerophosphoinositol 4,5-bisphosphate [and maybe, very slowly, of Ptdlns(4,5)P2]. Inhibition by 2,3-bisphosphoglycerate suggested that the enzyme has a particular affinity for pairs of vicinal monoester phosphates, and also raised the possibility that we might have been observing degradation of Ins(1,4,5)P3 by the previously described 2,3-bisphosphoglycerate phosphomonoesterase activity of the erythrocyte (Rapoport & Luebering, 1951) ; this activity represents a composite of the reversal of 2,3-bisphosphoglycerate synthase and a sidereaction catalysed by 2,3-bisphosphoglycerate mutase (Rose, 1980) . The 'apparent Km' for 2,3-bisphosphoglycerate of this composite activity is close to the K, (0.35 mM) for inhibition of Ins( 1,4,5)P3 breakdown by 2,3-bisphosphoglycerate. For several reasons, we consider it unlikely that the Ins(1,4,5)P3 activity that we have observed is a further facet of the activities of these 2,3-bisphosphoglycerate-metabolizing enzymes. The
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Ins(1,4,5)P3 phosphomonoesterase that we studied was tightly bound to the membrane, persisting in an isoionic ghost preparation and in low-ionic-strength ghosts that were washed with iso-osmotic saline; 2,3-bisphosphoglycerate phosphomonoesterase activity is mainly cytosolic (Rose, 1980) . Further, it has been reported that the 2,3-bisphosphoglycerate phosphatase activity is activated by 0.2mM-Ag+ and strongly inhibited by 0.2 mM-Cu2+; 0.2 mM-Ag+ almost abolished the activity of the Ins(1,4,5)P3 phosphomonoesterase and 0.2 mM-Cu2+ only weakly inhibited it (results not shown).
Human erythrocytes have a Ca2+-dependent membrane-bound polyphosphoinositide phosphodiesterase that releases Ins( 1 ,4,5)P3 from PtdIns(4,5)P2 (Allan & Michell, 1978; Downes & Michell, 1981a,b) , and the Ins(1,4,5)P3 phosphatase of the erythrocyte was first noted by virtue of its ability to hydrolyse the Ins(1,4,5)P3 released by this enzyme (Downes & Michell, 1981a) . However, there are cogent reasons for thinking that the polyphosphoinositide phosphodiesterase of the erythrocyte is never activated during the lifespan of the circulating healthy erythrocyte and that maybe it is a relic that remains from an earlier stage in cellular development (e.g. from erythropoiesis). If this is correct, then the same arguments apply to the Ins(1,4,5)P3 phosphomonoesterase; if no PtdIns(4,5)P2 ever breaks down by the phosphodiesterase route in the healthy mature erythrocyte then there can never be any substrate for the Ins(1,4,5)P3 phosphomonoesterase. We therefore wonder, as with the polyphosphoinositide phosphodiesterase , whether this Ins(1,4,5)P3 phosphomonoesterase may simply serve as an easily studied exemplar, but with a need for the function of Ins(1,4,5)P3 phosphomonoesterase to be defined by studies using other cells.
A general rolefor Ins(1,4,5)P3 phosphatases?
This raises the obvious question as to whether Ins(1,4,5)J3 is ever produced within cells other than the erythrocyte, and hence whether there is a need for an enzyme to degrade it. There are hints that suggest that such situations may be widespread. Abdel-Latif and his colleagues have defined a phosphodiesterase-mediated breakdown of Ptdlns(4,5)P2 in iris smooth muscle when stimulated by muscarinic cholinergic or a-adrenergic ligands (Abdel-Latif et al., 1978) , but they find that the majority of the released lipid head-groups accumulate in the tissue as inositol monophosphate rather than Ins(1,4,5)P3 (Akhtar & Abdel-Latif, 1980) . Indeed, they claim to have detected Ins(1,4,5)P3 phosphatase in iris smooth muscle (Akhtar & Abdel-Latif, 1980) . In previous experiments, Griffin & Hawthorne (1978) had seen a Ca2+-activated breakdown of Ptdlns(4,5)P2 in synaptosomes that led to accumulation of inositol bisphosphate rather than Ins(1,4,5)P3. They interpreted this as the result of the sequential action of PtdIns(4,5)P2 phosphomonoesterase and PtdIns4P phosphodiesterase, but they also acknowledged the alternative possibility of phosphodiesterase action followed by an Ins( 1 ,4,5)P3 phosphomonoesterase-catalysed production of inositol bisphosphate. The latter alternative now seems more likely. Most recently, we have found very rapid breakdown of PtdIns4P and Ptdlns(4,5)P2 in rat hepatocytes stimulated with Ca2+-mobilizing stimuli such as vasopressin Michell et al., 1982) . This response is very rapid [approx. 30% breakdown of Ptdlns(4,5)P2 in 1 mini, it has appropriate characteristics for it to be a candidate for a role in the coupling between receptor activation and Ca2+ mobilization and it seems likely to be catalysed by a phosphodiesterase.
It seems likely that Ins(1,4,5)P3 will be released from membrane-bound PtdIns(4,5)P2 into the cytosol in each of these situations, and that cells will therefore have a need to further metabolize this product. The importance of this degradative reaction may be accentuated by the fact that the high affinity of Ptdlns(4,5)P2 for bivalent cations resides mainly in its vicinal pair of phosphates (Hendrickson & Reinertsen, 1969) ; this grouping is preserved during the release of Ins(1,4,5)P3 but destroyed when the phosphomonoesterase removes the 5-phosphate. It is possible that Ins(1,4,5)P3 liberated by hormone action might have some function within a stimulated cell, in which case the presence in high activity of an enzyme capable of its degradation (and hence inactivation) might be expected. We would also anticipate that, in order for inositol and inositol lipid metabolism to continue freely, cells should possess additional phosphomonoesterase activities, either specific or non-specific, that are ultimately capable of returning the inositol of inositol trisphosphate to the free inositol pool of the cell.
A useful analytical tool?
Not only does the newly-discovered Ins(1,4,5)P3 phosphomonoesterase seem likely to provide the enzymic mechanism for a metabolic step that might have been anticipated, but it also promises to be a remarkably valuable analytical tool. One of the technical deficiencies that has prevented detailed study of the metabolism of the polyphosphoinositides has been the lack of readily available and simple tools with which to analyse the metabolic behaviour of the three phosphates in the headgroup of PtdIns(4,5)P2; for example, we do not even know the relative turnover rates of the two monoesterified phosphates. The ability of the Ins(1,4,5)P3 phosphomonoesterase of easily prepared erythrocyte ghosts to attack glycerophosphoinositol 4,5-bis-1982 phosphate, the water-soluble phosphate ester produced by treatment of Ptdlns(4,5)P2 with mild alkali, opens up the possibility of using sequential attack on glycerophosphoinositol 4,5-bisphosphate, first by Ins(1,4,5)P3 phosphatase to remove the 5-phosphate and then by an unspecific phosphatase to remove the 4-phosphate, to analyse the detailed metabolism of each of these three phosphates in PtdIns(4,5)P2.
